Home › Cancer (all types) › NCT05294302
Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer
A Randomized Controlled Trial of eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer
Who can join
All ages · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Participants must be the parent or primary caregiver of a child (ages 0 - 18 years old) diagnosed with cancer. * Participants must be able to speak and read English or Spanish. * Participants must have access to the internet through a computer or mobile device (e.g., smartphone, tablet). Exclusion Criteria: * PCCC are ineligible to participate if their child is not expected to live longer than six months from the time of potential recruitment
About the study
It is critical to provide accessible evidence-based psychosocial support to parents and caregivers of children with cancer (PCCC) in order to mitigate individual and family-level psychosocial risks. This effectiveness trial evaluates an eHealth intervention for English- and Spanish-speaking (PCCC) with study endpoints focused on decreasing negative psychosocial sequelae (acute distress, posttraumatic stress, and anxiety) and improving coping abilities (coping self-efficacy, cognitive coping strategies). The long-term goal of this research program is to sustain and disseminate an effective, scalable, high-reach, and cost-effective intervention to provide crucial support to PCCC across the pediatric cancer trajectory.
What is being tested
- eSCCIP/eSCCIP-SP (behavioral)
- Coping Space (behavioral)
Sponsor: Nemours Children's Clinic · Participants: 350 · Started: Apr 14, 2023
Contact the study team
- Kimberly Canter, Ph.D. · Phone: 3026514501
Official record on ClinicalTrials.gov — NCT05294302
Locations in the U.S.
| California | Children's Hospital Los Angeles, Los Angeles (Not yet recruiting) |
| Delaware | Nemours Children's Health, Delaware, Wilmington |
| Texas | MD Anderson Cancer Center, Houston (Not yet recruiting) |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.